PATENT CLAIM ANALYSIS

Application Number: 15881123
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["514", "006900"]

Abstract:
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.

Claim (Index 30):
The dosage form according to  claim 28 , wherein the gelatin is non-gelling fish gelatin.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.37931
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10513437', '14326939', '13110619', '12487116', '14947261']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8011272286590776
- 35 USC 102 Novelty (BERT): 0.5372162741898375
- Combined Prediction Score: 0.7747361332121536
- Mean Citation Score: 353.576544
- Max Citation Score: 361.85043
- Similarity Product: 300.1269651069473

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test